Search Orphan Drug Designations and Approvals
-
Generic Name: | (E)-N¿-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate |
---|---|
Date Designated: | 01/12/2017 |
Orphan Designation: | Treatment of Ewing's sarcoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Salarius Pharmaceuticals 2450 Holcombe Boulevard Suite J-608 Houston, Texas 77021 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-